Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)

Autor: Loibl, Sibylle, de la Pena, Lorena, Nekljudova, Valentina, Zardavas, Dimitrios, Michiels, Stefan, Denkert, Carsten, Rezai, Mahdi, Bermejo, Begoña, Untch, Michael, Lee, Soo Chin, Turri, Sabine, Urban, Patrick, Kümmel, Sherko, Steger, Guenther, Gombos, Andrea, Lux, Michael, Piccart, Martine J., Von Minckwitz, Gunter, Baselga, José, Loi, Sherene
Zdroj: In European Journal of Cancer November 2017 85:133-145
Databáze: ScienceDirect
Externí odkaz: